Top page Medical institution search Search Results - Doctors Yoko Ozawa

Yoko Ozawa（Kanto/Tokyo）

ophthalmology
Professor Ozawa

Professor Ozawa

Fujita Health University Haneda Clinic

Fujita Health University Haneda Clinic

Professor Ozawa
Fujita Health University Haneda Clinic

Professor

“Eye Specialist”

With deep expertise and advanced skills in retinal and vitreous care, I offer a full spectrum of services, including detailed eye examinations, genetic testing, drug treatments, and surgical procedures.

Based on extensive experience in basic research, including iPS cells, and cl ini cal re se arch th at su ppo rts diagnostic expertise, I provide flexible and personalized care tailored to your needs.

Clinical department/Main areas of expertise
  • ophthalmology
    Retinal and vitreous diseases　Detail
Specialized area
  • ● Retinal and vitreous diseases
    ● Regenerative medicine
    ● Age-related macular degeneration
    ● Diabetic retinopathy and diabetic macular edema
    ● Epiretinal membrane and macular hole
    ● Retinitis pigmentosa and macular dystrophy
    ● Drug therapies and vitreoretinal surgery, etc.　Detail
Qualifications/Academia/Position
  • Doctor of Medicine (MD)
  • Ophthalmology Specialist,
  • Certified in Photodynamic Therapy (PDT)
  • Specialist (Japanese Society of Anti-Aging Medicine)
Affiliated hospital
FUJITA HEALTH UNIVERSITY HANEDA CLINIC
location
〒144-0041
1-1-4, Hanedakuko, Ota-ku, Haneda Innovation City Zone A Google Map Map
Biography
1992
Graduated from Keio University School of Medicine
1997
Assistant, Department of Ophthalmology, Keio University School of Medicine
2007
Assistant Professor, Department of Ophthalmology, Keio University School of Medicine
2008
Associate Professor, Department of Ophthalmology, Keio University School of Medicine
2009
Chief, Retinal Cell Biology Laboratory, Department of Ophthalmology, Keio University School of Medicine (Concurrent Position)
2020
Associate Professor, Department of Ophthalmology, Keio University School of Medicine (Concurrent Position)
2022 －2023
Director of Ophthalmology, St. Luke's International Hospital Clinical and Research Professor, St. Luke's International University
2023
Professor, Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center Tokyo
paper
  • 1. Nagai N, Matsubara H, Terasaki H, Hirano T, Kato A, Miki A, Hirai H, Murao F, Imaizumi H, Gomi F, Mitamura Y, Ogata N, Kusuhara S, Yasukawa T, Murata T, Sakamoto T, Kondo M, Shinoda H, Ozawa Y*. Extent of complete retinal pigment epithelial and outer retinal atrophy with foveal center involvement is associated with visual acuity. Ophthalmology Science. 2024. In press.
  • 2. Ozawa Y¶*, Yoshihara K, Mezghani M, Pierzchała P, Nikodem M, Barbier S, Nomoto M, Aitoku Y. Recent daily life burdens associated with neovascular age-related macular degeneration involve difficulties in use of electronic devices. Sci Rep. 2024 Jun 20;14(1):14181.
  • 3. Nagai N, Mushiga Y, Ozawa Y*. Diabetic choriocapillaris flow deficits affect the outer retina and are related to hemoglobin A1c and systolic blood pressure levels. Sci Rep. 2023 Dec 19;13(1):22570. 4. Ozawa Y¶*, Toda E, Homma K, Osada H, Nagai N, Tsubota K, Okano H. Effects of Epigenetic Modification of PGC-1α by a Chemical Chaperon on Mitochondria Biogenesis and Visual Function in Retinitis Pigmentosa Cells 2022, 11, 1497. 5. Homma K, Toda E, Osada H, Nagai N, Era T, Tsubota K, Okano H, Ozawa Y*. Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol. 2021. Feb 28; 41:101921.
  • 4. Ozawa Y¶*, Toda E, Homma K, Osada H, Nagai N, Tsubota K, Okano H. Effects of Epigenetic Modification of PGC-1α by a Chemical Chaperon on Mitochondria Biogenesis and Visual Function in Retinitis Pigmentosa Cells 2022, 11, 1497.
  • 5. Homma K, Toda E, Osada H, Nagai N, Era T, Tsubota K, Okano H, Ozawa Y*. Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol. 2021. Feb 28; 41:101921.
others
■ Main Research
Surgical treatment of retinal and vitreous diseases that progress with age, such as age-related macular degeneration and diabe tic retinopathy, as well as macular diseases directly affecting vision, including epiretinal membranes and macular holes.



■ Awards
2016: Global Ophthalmology Awards Program Research Award
2007: Sanshikai Encouragement Award of Keio University School of Medicine

This doctor's treatment program

  • Inquiry about Second Opinion Program for Surgery by Dr. Ozawa　(Fujita Health University Haneda Clinic)

    ophthalmology

    FUJITA HEALTH UNIVERSITY HANEDA CLINIC（Kanto/Tokyo）

    Inquiry about Second Opinion Program for Surgery by Dr. Ozawa　(Fujita Health University Haneda Clinic)

    See details
Back to search results list Back to search page